Skip to content

S. 2205 · 118th Congress (2023–2025)

ISLET Act

This bill removes pancreatic islets that are donated from human cadavers from regulation as a drug or biological product by the Food and Drug Administration (FDA). (Islets are groups of cells, including those that make insulin, in the pancreas, and islet transplantation is an experimental treatment for certain conditions, such as type 1 diabetes.)

Current FDA guidance treats pancreatic islets as a biological product, which makes them subject to the biological license application process and related standards for manufacturing practices, safety, identity, purity, and potency.

The bill, instead, treats human cadaveric islets as organs, which makes them subject to the regulatory framework that governs the allocation, safety, and efficacy of organ donation and transplantation. That framework, developed by the Health Resources and Services Administration, is carried out by contract through the Organ Procurement and Transplantation Network. (The network is a public-private partnership that links the professionals involved in the U.S. donation and transplantation system.)

Specifically, the bill defines human cadaveric islets as organs and excludes them from definitions related to the regulation of drugs and biological products.

Show official title

A bill to regulate human cadaveric islets for transplantation as organs.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 2205’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Mike Lee (R-UT)
Cosponsors
3 cosponsors

2 original · 1 later

  1. Sen. Marsha Blackburn (R-TN)· Original · Jun 22, 2023
  2. Sen. Ted Budd (R-NC)· Original · Jun 22, 2023
  3. Sen. Rand Paul (R-KY)· Later · Jul 11, 2023
Policy area
Health
Subjects
  • Administrative law and regulatory procedures
  • Congressional oversight
  • Department of Health and Human Services
  • Digestive and metabolic diseases
  • Organ and tissue donation and transplantation

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Sources
  3. Expired

    Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Jun 22, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (3)
  1. ISLET Act

    Display title, Short title · Introduced in Senate

  2. Increase Support for Life-saving Endocrine Transplantation Act

    Short title · Introduced in Senate

  3. A bill to regulate human cadaveric islets for transplantation as organs.

    Official title · Introduced in Senate